Brief: Pulmatrix Receives Fast Track Designation For Pulmazole For The Treatment Of Asthma-Abpa
30/01/2020 13:02
Jan 30 (Reuters) - Pulmatrix Inc PULM.O :
* PULMATRIX RECEIVES FAST TRACK DESIGNATION FOR PULMAZOLE
FOR THE
TREATMENT OF ASTHMA-ABPA
Source text for Eikon: ID:nPn7S7HGHa
Further company coverage: PULM.O
((Briefs@thomsonreuters.com;))
Recent news on Pulmatrix
See all newsBrief: Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger
Pulmatrix Q2 loss narrows on clinical development hold
Pulmatrix Q1 net loss narrows, clinical development on hold
Brief: Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger
NASDAQ RESUMED AT 09:00 AM